Unique ID issued by UMIN | UMIN000016860 |
---|---|
Receipt number | R000019571 |
Scientific Title | Comparison examination of microbiota in mouth, intestine and vagina before and after medication of a raw bacillus agent (an active bacterial probiotics, Bio-Three) to the threatened premature delivery patient who requires in-hospital treatment, and examination about validity of preterm delivery medical treatment |
Date of disclosure of the study information | 2015/03/21 |
Last modified on | 2017/12/11 14:28:48 |
Comparison examination of microbiota in mouth, intestine and vagina before and after medication of a raw bacillus agent (an active bacterial probiotics, Bio-Three) to the threatened premature delivery patient who requires in-hospital treatment, and examination about validity of preterm delivery medical treatment
Comparison examination of microbiota in mouth, intestine and vagina before and after medication of a raw bacillus agent to threatened preterm delivery, and examination about validity of preterm delivery medical treatment
Comparison examination of microbiota in mouth, intestine and vagina before and after medication of a raw bacillus agent (an active bacterial probiotics, Bio-Three) to the threatened premature delivery patient who requires in-hospital treatment, and examination about validity of preterm delivery medical treatment
Comparison examination of microbiota in mouth, intestine and vagina before and after medication of a raw bacillus agent to threatened preterm delivery, and examination about validity of preterm delivery medical treatment
Japan |
threatened preterm delivery
Obstetrics and Gynecology |
Others
YES
To perform a raw bacillus agent (Bio-Three®, 6 tablets per day) medication to patients of threatened preterm delivery who need in-hospital treatment and
To evaluate a change of microbiota in mouth, intestine and vagina before and after medication by the T-RFLP (Terminal restriction fragment length polymorphism) method and meta-genomics analysis using a next-generation sequencer
Safety,Efficacy
Not applicable
a change of microbiota in mouth, intestine and vagina
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
A raw bacillus agent (Bio-Three 6 tablets per day, 14 days) is prescribed.
20 | years-old | <= |
Not applicable |
Female
a patient of threatened preterm delivery (tocolysis index, 2 to 6) who needs in-hospital treatment, who was transferred from other hospitals or was out-patient in our hospital at 22 to 34 weeks of gestation
1) multiple pregnancy
2) previous medication of antibiotics within 14 days
3) premature rupture of the membranes
4) tocolysis index of 7 or higher (there is a possibility of becoming a preterm delivery within one week)
5) allergy to Bio-Three
6) ulcerative colitis and Crohn's disease
60
1st name | |
Middle name | |
Last name | Shigeru Saito |
University of Toyama
OB/GYN
2630 Sugitani Toyama
076-434-7355
s30saito@med.u-toyama.ac.jp
1st name | |
Middle name | |
Last name | Arihiro Shiozaki |
University of Toyama
Obstetrics and Gynecology
2630 Sugitani, Toyama
076-434-7357
s33shio@med.u-toyama.ac.jp
University of Toyama
Toa Pharmaceutical Co., LTD.
Profit organization
Japan
NO
2015 | Year | 03 | Month | 21 | Day |
Unpublished
Terminated
2014 | Year | 01 | Month | 01 | Day |
2014 | Year | 03 | Month | 01 | Day |
2015 | Year | 03 | Month | 21 | Day |
2017 | Year | 12 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019571